Intercept Pharmaceuticals Earnings Call News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Intercept pharmaceuticals earnings call. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Intercept Pharmaceuticals Earnings Call Today - Breaking & Trending Today

Intercept Pharmaceuticals Inc (ICPT) Q1 2021 Earnings Call Transcript


Operator
Welcome to the Q1 2021 Intercept Pharmaceuticals Earnings Call. My name is Anette, and I ll be your operator for today s call. [Operator Instructions]
I will now turn the call over to Lisa DeFrancesco. Lisa, you may begin.
Lisa DeFrancesco
Senior Vice President of Investor Relations and Corporate Affairs
Thank you. Good morning, and thank you for joining us on today s call. This morning, we issued a press release announcing our first quarter 2021 results and financial position, which is available on our website at www.interceptpharma.com. Before we begin our discussion, I d like to note that during our call, we will be making forward-looking statements, including statements regarding our approved product and clinical development program; certain regulatory matters; and our strategy, prospects, financial guidance and future commercial and financial performance. Listeners are cautioned not to place undue reliance on these forward-looking statements, w ....

United States , Gail Cawkwell , Jerome Durso , Raymond James , Chris Weyer , Linda Richardson , Steve Seedhouse , Jay Olson Oppenheimer , Lisa Defrancesco , Michael Yee , Jerry Durso , Brian Abrahams , Jay Olson , Rocco Venezia , David Cithu , Mark Pruzanski , Ryan Deschner , Piper Sandler , Jesse Piper Sandler , Navin Jacob , Ryan Deschner Raymond James , Thomas Smith , Emily Cantor Fitzgerald , Cantor Fitzgerald , Intercept Pharmaceuticals Inc , Intercept Pharmaceuticals Earnings Call ,

Intercept Pharmaceuticals Inc (ICPT) Q4 2020 Earnings Call Transcript


Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Fourth Quarter 2020 Intercept Pharmaceuticals Earnings Call. [Operator Instructions]
I d now like to hand the conference over to your host today, Ms. Lisa DeFrancesco, Senior Vice President, Investor Relations and Corporate Affairs. Please go ahead.
Lisa DeFrancesco
Senior Vice President, Corporate Affairs & Investor Relations
Thank you. Good morning, and thank you for joining us on today s call. This morning we issued a press release announcing our fourth quarter and full year 2020 results and financial position, which is available on our website at www.interceptpharma.com.
Before we begin our discussion, I d like to note that during the call we will be making forward-looking statements, including statements regarding our approved products and clinical development program, certain regulatory matters and our strategy, prospects, financial guidance and future, commercial and fina ....

Gail Cawkwell , Jerome Durso , Jerry Durso , Lisa Defrancesco , Sandip Kapadia , Intercept Pharmaceuticals Inc , Corporate Affairs Investor Relations , Intercept Pharmaceuticals Earnings Call , Corporate Affairs , Fourth Quarter , Pharmaceuticals Earnings , Senior Vice President , Investor Relations , Vice President , Chief Financial Officer , Medical Affairs , Acting Chief Medical , Chief Executive Officer , ஜெரோம் துர்சோ , ஜெர்ரி துர்சோ , லிசா டேபிரான்செஸ்கோ , சண்டீப் கபாடியா , இடைமறிப்பு மருந்துகள் இன்க் , பெருநிறுவன வாழ்க்கைத்தொழில்கள் முதலீட்டாளர் உறவுகள் , பெருநிறுவன வாழ்க்கைத்தொழில்கள் , நான்காவது காலாண்டு ,